Statistics for Mesa Laboratories (id:7825 MLAB)
Valuation metrics
Market cap
592.51M
Enterprise value
744.67M
Trailing P/E (ttm)
546.59
Forward P/E
14.84
PEG ratio
14.84
Price/Sales (ttm)
2.59
Price/Book (mrq)
3.66
Enterprise Value/Revenue
3.26
Enterprise Value/EBITDA
17.90
Overview
Shares outstanding
5.43M
Float
5.29M
Shares short
150.21K
% Held by insiders
0.06%
% Held by institutions
0.92%
Average volume (10 days)
42.28K
Average volume (90 days)
Price summary
52-Week low
83.68
52-Week high
141.17
52-Week change
20.76%
Beta
0.86
50-Day moving average
121.64
200-Day moving average
111.68
Dividends and splits
Forward annual dividend rate
0.64
Forward annual dividend yield
0.01
Trailing annual dividend rate
0.64%
Trailing annual dividend yield
0.01
5-Year annual dividend yield
0.37
Payout ratio
3.76
Dividend date
December 16th, 2024
Ex-dividend date
November 29th, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
March 31th, 2024
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-107.56%
Operating margin
6.85%
Operational effectiveness
Return on assets
1.69%
Return on equity
-89.46%
Income statement
Revenue (ttm)
42.30
Revenue per share (ttm)
42.30
Quarterly revenue growth (yoy)
Gross profit (ttm)
133.25M
EBITDA
36.16M
Net income to common (ttm)
-245,651,008.00
Diluted EPS (ttm)
-45.62
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
26.00M
Total cash per share (mrq)
4.79
Total debt (mrq)
222.86M
Total Debt/Equity (mrq)
138.03
Current ratio (mrq)
70.50%
Book value per share (mrq)
29.79
Cash flow
Cash flow statement
40.12M
Levered free cash flow (LFCF)
48.73M